TITLE

Common variants in P2RY11 are associated with narcolepsy

AUTHOR(S)
Kornum, Birgitte R.; Kawashima, Minae; Faraco, Juliette; Ling Lin; Rico, Thomas J.; Hesselson, Stephanie; Axtell, Robert C.; Kuipers, Hedwich; Weiner, Karin; Hamacher, Alexandra; Kassack, Matthias U.; Fang Han; Knudsen, Stine; Jing Li; Xiaosong Dong; Winkelmann8,9,10, Juliane; Plazzi, Giuseppe; Nevsimalova, Sona; Seung-Chul Hong; Honda, Yutaka
PUB. DATE
January 2011
SOURCE
Nature Genetics;Jan2011, Vol. 43 Issue 1, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Growing evidence supports the hypothesis that narcolepsy with cataplexy is an autoimmune disease. We here report genome-wide association analyses for narcolepsy with replication and fine mapping across three ethnic groups (3,406 individuals of European ancestry, 2,414 Asians and 302 African Americans). We identify a SNP in the 3′ untranslated region of P2RY11, the purinergic receptor subtype P2Y11 gene, which is associated with narcolepsy (rs2305795, combined P = 6.1 × 10−10, odds ratio = 1.28, 95% CI 1.19-1.39, n = 5689). The disease-associated allele is correlated with reduced expression of P2RY11 in CD8+ T lymphocytes (339% reduced, P = 0.003) and natural killer (NK) cells (P = 0.031), but not in other peripheral blood mononuclear cell types. The low expression variant is also associated with reduced P2RY11-mediated resistance to ATP-induced cell death in T lymphocytes (P = 0.0007) and natural killer cells (P = 0.001). These results identify P2RY11 as an important regulator of immune-cell survival, with possible implications in narcolepsy and other autoimmune diseases.
ACCESSION #
57244630

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics